Work

Results from a phase Ib study of trastuzumab emtansine (T-DM1), paclitaxel (T), and pertuzumab (P) in patients with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.528

Authors: Shanu Modi, Anthony D. Elias, Patricia LoRusso, Meghna Samant, Ellie Guardino, Betsy Althaus, Ian E. Krop

Institutions: Memorial Sloan Kettering Cancer Center, University of Colorado Cancer Center, The Barbara Ann Karmanos Cancer Institute, Roche (Switzerland), Genentech, Dana-Farber Cancer Institute

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3011513523

Cites:

Cited by: 5

Related to: 10